Upstream / Downstream

pathwayImage

Explore pathways related to this product.

Antibody Guarantee

CST Antibody Performance Guarantee

LEARN MORE  

To get local purchase information on this product, click here

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

We recommend the following alternatives

W IP   IF   ChIP H M R XP
REACTIVITY SENSITIVITY MW (kDa) SOURCE
50 Rabbit

Product Usage Information

Storage: Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.

Specificity / Sensitivity

STF-1 Antibody recognizes endogenous levels of total STF-1 protein. This antibody does not cross-react with LRH-1/NR5A2.


Species predicted to react based on 100% sequence homology: Monkey, Bovine, Pig, Horse

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu184 of human STF-1 protein. Antibodies are purified by protein A and peptide affinity chromatography.

The orphan nuclear receptor, steroidogenic factor 1 (STF-1, also called Ad4BP), is encoded by the NR5A1 gene and plays an instrumental role in directing the transcriptional control of steroidogenesis (1). Initially identified as a tissue-specific transcriptional regulator of cytochrome P450 steroid hydroxylases, research studies of both global (2) and tissue-specific knockout mice (3-6) have demonstrated that STF-1 is required for the development of adrenal glands, gonads, ventromedial hypothalamus, and for the proper functioning of pituitary gonadotropes. Indeed, humans with mutations that render STF-1 transcriptionally inactive can present with testicular failure, ovarian failure, and adrenal insufficiency (7,8). Furthermore, dysregulation of STF-1 has been linked to diseases such as endometriosis (9) and adrenocortical carcinoma (10).

Like other nuclear hormone receptors, STF-1 has a modular domain structure composed of an amino-terminal zinc finger DNA-binding domain, a ligand-binding domain, a carboxy-terminal AF-2 activation domain, and a hinge region with AF-1-like activation activity. STF-1 also contains a fushi tarazu factor 1 box, which functions as an accessory DNA binding domain (11). STF-1 is primarily phosphorylated at Ser203, which is thought to enhance its transcriptional activity by promoting complex formation with transcriptional cofactors (12). In addition to phosphorylation at Ser203, STF-1 is subject to SUMO conjugation and acetylation at ε-amino groups of target lysine residues. Whereas SUMOylation represses STF-1 function (13,14), acetylation enhances its transcriptional activity (15).


1.  Parker, K.L. and Schimmer, B.P. (1997) Endocr Rev 18, 361-77.

2.  Luo, X. et al. (1994) Cell 77, 481-90.

3.  Zhao, L. et al. (2001) Development 128, 147-54.

4.  Jeyasuria, P. et al. (2004) Mol Endocrinol 18, 1610-9.

5.  Pelusi, C. et al. (2008) Biol Reprod 79, 1074-83.

6.  Zhao, L. et al. (2008) Mol Endocrinol 22, 1403-15.

7.  Achermann, J.C. et al. (1999) Nat Genet 22, 125-6.

8.  Lourenço, D. et al. (2009) N Engl J Med 360, 1200-10.

9.  Bulun, S.E. et al. (2009) Mol Cell Endocrinol 300, 104-8.

10.  Figueiredo, B.C. et al. (2005) J Clin Endocrinol Metab 90, 615-9.

11.  Little, T.H. et al. (2006) Mol Endocrinol 20, 831-43.

12.  Hammer, G.D. et al. (1999) Mol Cell 3, 521-6.

13.  Chen, W.Y. et al. (2004) J Biol Chem 279, 38730-5.

14.  Lee, F.Y. et al. (2011) Dev Cell 21, 315-27.

15.  Chen, W.Y. et al. (2005) Mol Cell Biol 25, 10442-53.


Entrez-Gene Id 2516
Swiss-Prot Acc. Q13285


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
Anti-FLAG is a registered trademark of Sigma-Aldrich Biotechnology.